Christopher Baeza (Chris)

Christopher Baeza has significant experience advising companies and their boards of directors, executive management and legal teams in public and private mergers & acquisitions, joint ventures, securities compliance, corporate restructuring, corporate finance and other complex transactions. In addition, he advises clients in other corporate, securities, strategic and business-related matters, including corporate governance, activist defense, stockholder and compliance matters, SEC reporting obligations and disclosure issues, and general corporate and commercial matters.

Mr. Baeza has been involved in many notable domestic and cross-border M&A and other corporate transactions representing acquirers, sellers and targets, including:

• Southwestern Energy in its $870 million acquisition of Montage Resources, $2.7 billion acquisition of Indigo Natural Resources, LLC, and $1.85 billion acquisition of GEP Haynesville, LLC;
• ONEOK, Inc. in its acquisition of all of the outstanding common units of ONEOK Partners, L.P. for $9.3 billion;
• Noble Energy, Inc. in its $3.2 billion acquisition of Clayton Williams Energy, Inc.;
• Leidos Holdings, Inc. in a Reverse Morris Trust transaction to combine with Lockheed Martin Corporation’s Information Systems & Global Solutions business;
• Hershey Co. in its $584 million acquisition of Chinese confectionary company Shanghai Golden Monkey Food Joint Stock Co.;
• Frontier Communications in its $2 billion acquisition of certain wireline assets from AT&T;
• Dover Corporation in its spin-off of Knowles Corporation into a stand-alone publicly traded company;
• DigitalGlobe, Inc. in its $900 million merger with GeoEye Inc.; and
• Anheuser-Busch InBev in its $20.1 billion acquisition of the remaining stake of Mexico’s Grupo Modelo, S.A.B. de C.V that it did not already own.

Prior to joining King & Spalding, Mr. Baeza was an attorney with Skadden, Arps, Slate, Meagher & Flom LLP in New York and Houston, and has experience as in-house counsel supporting domestic and international corporate transactions and investments for Henry Schein, Inc., one of the world’s largest distributors of healthcare products and services.